<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">APH</journal-id>
<journal-id journal-id-type="hwp">spaph</journal-id>
<journal-id journal-id-type="nlm-ta">Asia Pac J Public Health</journal-id>
<journal-title>Asia-Pacific Journal of Public Health</journal-title>
<issn pub-type="ppub">1010-5395</issn>
<issn pub-type="epub">1941-2479</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1010539510385220</article-id>
<article-id pub-id-type="publisher-id">10.1177_1010539510385220</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Hepatitis B Infection in Vietnam</article-title>
<subtitle>Current Issues and Future Challenges</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Nguyen</surname><given-names>Van T. T.</given-names></name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-1010539510385220">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-1010539510385220"><label>1</label>The University of New South Wales, Sydney, New South Wales, Australia</aff>
<author-notes>
<corresp id="corresp1-1010539510385220">Van TT Nguyen, School of Public Health and Community Medicine, The University of New South Wales, Sydney, New South Wales 2052, Australia Email: <email>v.nguyen@unsw.edu.au</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>3</month>
<year>2012</year>
</pub-date>
<volume>24</volume>
<issue>2</issue>
<fpage>361</fpage>
<lpage>373</lpage>
<permissions>
<copyright-statement>© 2012 APJPH</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">Asia-Pacific Academic Consortium for Public Health</copyright-holder>
</permissions>
<abstract>
<p>Hepatitis B virus (HBV) infection remains a major public health problem in Vietnam. Recent studies have found that prevalence of current HBV infection (HBsAg+) ranges from 10% to 20% in the general population and 20% to 40% among injecting drug users and HIV+ patients. However, HBV prevention and control in Vietnam relies heavily on universal infant vaccination program and HBsAg screening for blood donors. Currently, HBV prevention and control is underfunded by the government and receives little support from international agencies. HBV-related liver disease will continue to create a heavy burden for public health in Vietnam in the next several decades unless appropriate interventions are undertaken urgently. Establishment of a national strategy for HBV prevention and control is crucial to develop and implement effective interventions.</p>
</abstract>
<kwd-group>
<kwd>hepatitis B infection</kwd>
<kwd>liver disease burden</kwd>
<kwd>HBV prevention and control</kwd>
<kwd>Vietnam</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1010539510385220" sec-type="intro">
<title>Introduction</title>
<p>Hepatitis B virus (HBV) remains one of the most common and serious etiology of liver disease despite the effective HBV vaccine introduced 25 years ago. Worldwide, of 350 million people chronically infected with the virus, 600 000 persons die each year because of either acute or chronic consequences of the infection.<sup><xref ref-type="bibr" rid="bibr1-1010539510385220">1</xref></sup> In Vietnam, an estimated 8.4 million people live with chronic HBV infection resulting in 23 300 HBV-related deaths in 2005.<sup><xref ref-type="bibr" rid="bibr2-1010539510385220">2</xref></sup> In many areas, prevalence of HBsAg positivity is as high as 15% to 20% of the general population.<sup><xref ref-type="bibr" rid="bibr3-1010539510385220">3</xref>-<xref ref-type="bibr" rid="bibr8-1010539510385220">8</xref></sup> Owing to late introduction of HBV vaccine, large population (84 million people estimated in 2006) and inadequate public health responses against the disease, HBV infection remains a major public health problem in Vietnam and could be a huge challenge in the future. However, HBV infection has not been considered as a serious public health issue as it should be. HBV-related liver disease has not been listed in the top 10 of either highest mortality or morbidity diseases, according to health statistics from the Ministry of Health. The reason is that HBV-related morbidity and mortality are classified in different categories, including acute and chronic hepatitis B, liver cirrhosis and hepatocellualr carcinoma (HCC), or liver failure. Hepatitis B infection is not notifiable in Vietnam; therefore, it is difficult to have collective data at national level regarding morbidity as well as mortality. This article will review the epidemiology of hepatitis B infection in Vietnam and identify the current issues and future challenges regarding prevention of hepatitis B–related liver disease to assist policy makers in combating the disease.</p>
</sec>
<sec id="section2-1010539510385220">
<title>Epidemiology of Hepatitis B in Vietnam</title>
<sec id="section3-1010539510385220">
<title>Literature Review</title>
<p>Epidemiological data on HBV at national level are very limited. To have an overview about epidemiology of HBV infection in Vietnam, literature review was conducted based on both electronic database and manual search. Publications in English were retrieved from Medline and Pubmed database using keywords “hepatitis B virus,” “hepatitis B infection,” and “hepatitis B” in combination with “Vietnam” without any limitations. For publications in Vietnamese, because of the unavailability of electronic version of local publication, a manual search was conducted in main libraries in Vietnam, including National Library, the Central Institute of Medical Science Information, and libraries of several medical universities, including Hanoi Medical University, Military Academy of Medicine, and Thai Binh Medical University. In addition, the lists of references in selected publications were scanned for additional articles. Since number of Vietnamese publications on HBV infection is limited, any articless reporting HBsAg prevalence with or without other markers were selected. Studies with sample size less than 100 were not included unless the study populations were children or high-risk groups. No attempt was made to contact authors for clarifications or further details of data as corresponding authors were not indicated and no authors’ contact details were provided in any of the local publications.</p>
</sec>
<sec id="section4-1010539510385220">
<title>Prevalence of Hepatitis B Infection in Vietnam</title>
<p>Prevalence of HBsAg in healthy subjects ranges from 5.7% to 24.7% depending on study setting and study subjects. There was no temporal trend in relation to prevalence of HBV markers of the general population (<xref ref-type="table" rid="table1-1010539510385220">Table 1</xref> and <xref ref-type="fig" rid="fig1-1010539510385220">Figure 1</xref>) as only cohort born after introduction of universal HBV vaccination program are protected from HBV infection whereas at least 10% of the population has already been infected with HBV. Thus, reduction in HBsAg prevalence due to vaccination would only be observed in the cohort born after introduction of universal infant HBV vaccination program. Further study on the effect of universal HBV vaccination program in Vietnam should be conducted. Most previous studies reported HBsAg prevalence within a range of 10% to 20% whereas prevalence of anti-HBs and anti-HBc were less reported. One study of children born before HBV vaccination program found anti-HBs prevalence of 5.3% but in the general population or healthy subjects it ranges from 16% to 41% (<xref ref-type="table" rid="table1-1010539510385220">Table 1</xref>). Although anti-HBc is considered as the main indicator for past infection of HBV, only few studies provided such data. In the studies conducted by Chau,<sup><xref ref-type="bibr" rid="bibr9-1010539510385220">9</xref></sup> Hipgrave et al,<sup><xref ref-type="bibr" rid="bibr3-1010539510385220">3</xref></sup> Chu et al,<sup><xref ref-type="bibr" rid="bibr10-1010539510385220">10</xref></sup> the prevalence of anti-HBc was between 50% and 55%. However, it was reported to be 70% to 75% by La<sup><xref ref-type="bibr" rid="bibr11-1010539510385220">11</xref></sup> and Nguyen et al,<sup><xref ref-type="bibr" rid="bibr8-1010539510385220">8</xref></sup> except one study provided anti-HBc prevalence of 6% in children 3 to 6 years old. This discrepancy could be explained by the differences in study methods and study population between the studies. Compared to other countries in the region where universal HBV vaccination program was introduced in early 1980s or 1990s, prevalence of HBV infection in Vietnam remains high. Prevalence of HBV infection in Taiwan, for instance, has substantially reduced, particularly in teenagers, after implementing universal and catch-up HBV vaccination programs covering age from infants to teenagers in 1986.<sup><xref ref-type="bibr" rid="bibr12-1010539510385220">12</xref>-<xref ref-type="bibr" rid="bibr15-1010539510385220">15</xref></sup> Thailand, Malaysia, and Singapore, where universal HBV vaccination program was implemented earlier have also achieved a reduction in HBV prevalence, particularly in the cohort born after introduction of the HBV vaccine.<sup><xref ref-type="bibr" rid="bibr16-1010539510385220">16</xref>-<xref ref-type="bibr" rid="bibr18-1010539510385220">18</xref></sup></p>
<table-wrap id="table1-1010539510385220" position="float">
<label>Table 1.</label>
<caption>
<p>Prevalence of HBV Infection in the General Population or Healthy Individuals in Vietnam</p>
</caption>
<graphic alternate-form-of="table1-1010539510385220" xlink:href="10.1177_1010539510385220-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">References</th>
<th align="center">Study Sample (n)</th>
<th align="center">Study Setting</th>
<th align="center">Age Group<sup><xref ref-type="table-fn" rid="table-fn2-1010539510385220">a</xref></sup></th>
<th align="center">HBsAg (%)</th>
<th align="center">Anti-HBs (%)</th>
<th align="center">Anti-HBc (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Tran, 1986<sup><xref ref-type="bibr" rid="bibr19-1010539510385220">19</xref></sup></td>
<td>General population (1304)</td>
<td>Hanoi city</td>
<td>0-&gt;60</td>
<td>11.4<sup><xref ref-type="table-fn" rid="table-fn3-1010539510385220">b</xref></sup></td>
<td align="center">—</td>
<td align="center">—</td>
</tr>
<tr>
<td>Chau, 1995<sup><xref ref-type="bibr" rid="bibr9-1010539510385220">9</xref></sup></td>
<td>General population (1801)</td>
<td>Kien Giang province</td>
<td>3 mo-87 y</td>
<td>11.0<sup><xref ref-type="table-fn" rid="table-fn2-1010539510385220">a</xref></sup></td>
<td>37.5</td>
<td>54.1</td>
</tr>
<tr>
<td>Nguyen et al, 2007<sup><xref ref-type="bibr" rid="bibr8-1010539510385220">8</xref></sup></td>
<td>General population (837)</td>
<td>Thai Binh</td>
<td>16-82</td>
<td>19.0</td>
<td>41.0</td>
<td>68.2</td>
</tr>
<tr>
<td>Le, 2007<sup><xref ref-type="bibr" rid="bibr20-1010539510385220">20</xref></sup></td>
<td>General population (1146)</td>
<td>Lao Cai province</td>
<td>&lt;5-&gt;18</td>
<td>11.0</td>
<td align="center">—</td>
<td align="center">—</td>
</tr>
<tr>
<td>Hipgrave et al, 2003<sup><xref ref-type="bibr" rid="bibr3-1010539510385220">3</xref></sup></td>
<td>General population (1579)</td>
<td>Thanh Hoa province</td>
<td>9 mo-40 y</td>
<td>16.8</td>
<td align="center">—</td>
<td>49.5</td>
</tr>
<tr>
<td>Duong et al, 2009<sup><xref ref-type="bibr" rid="bibr21-1010539510385220">21</xref></sup></td>
<td>General population (383)</td>
<td>Thai Nguyen province</td>
<td>18-70</td>
<td>8.8</td>
<td align="center">—</td>
<td>44.6</td>
</tr>
<tr>
<td>Kakumu et al, 1998<sup><xref ref-type="bibr" rid="bibr22-1010539510385220">22</xref></sup></td>
<td>Healthy subjects (890)</td>
<td>Dalat city, Lam Dong province</td>
<td>2-81</td>
<td>5.7</td>
<td align="center">—</td>
<td align="center">—</td>
</tr>
<tr>
<td>Vu, 1998<sup><xref ref-type="bibr" rid="bibr23-1010539510385220">23</xref></sup></td>
<td>Healthy subjects (817)</td>
<td>Thanh Hoa city</td>
<td>0-60</td>
<td>11.7</td>
<td>25.5</td>
<td align="center">—</td>
</tr>
<tr>
<td>Nguyen et al, 2000<sup><xref ref-type="bibr" rid="bibr24-1010539510385220">24</xref></sup></td>
<td>Healthy subjects (496)</td>
<td>Tay Nguyen</td>
<td>&lt;15-&gt;45</td>
<td>12.9</td>
<td align="center">—</td>
<td align="center">—</td>
</tr>
<tr>
<td>Duong et al, 2000<sup><xref ref-type="bibr" rid="bibr25-1010539510385220">25</xref></sup></td>
<td>Healthy subjects (220)</td>
<td>Ha Tinh province</td>
<td>NR</td>
<td>7.7</td>
<td>31.4</td>
<td align="center">—</td>
</tr>
<tr>
<td>Tran et al, 2003<sup><xref ref-type="bibr" rid="bibr26-1010539510385220">26</xref></sup></td>
<td>Healthy subjects (100)</td>
<td>Ho Chi Minh city</td>
<td>NR</td>
<td>10.0<sup><xref ref-type="table-fn" rid="table-fn4-1010539510385220">c</xref></sup></td>
<td align="center">—</td>
<td align="center">—</td>
</tr>
<tr>
<td>La, 1995<sup><xref ref-type="bibr" rid="bibr11-1010539510385220">11</xref></sup></td>
<td>General health check-up (2573)</td>
<td>Ho Chi Minh city and Ben Tre town</td>
<td>10-&gt;50</td>
<td>13.3</td>
<td>30.9</td>
<td>74.7</td>
</tr>
<tr>
<td>Nguyen et al, 1992<sup><xref ref-type="bibr" rid="bibr27-1010539510385220">27</xref></sup></td>
<td>Healthy subjects (675)</td>
<td>Hanoi city</td>
<td>18-40</td>
<td>24.7</td>
<td align="center">—</td>
<td align="center">—</td>
</tr>
<tr>
<td>Vien et al, 1996<sup><xref ref-type="bibr" rid="bibr4-1010539510385220">4</xref></sup></td>
<td>Factory workers (329)</td>
<td>Nha Trang city</td>
<td>NR</td>
<td>18.2</td>
<td>37.1</td>
<td align="center">—</td>
</tr>
<tr>
<td>Cao et al, 2003<sup><xref ref-type="bibr" rid="bibr28-1010539510385220">28</xref></sup></td>
<td>Factory workers (2400)</td>
<td>Hai Duong province</td>
<td>16-60</td>
<td>12.0</td>
<td align="center">—</td>
<td align="center">—</td>
</tr>
<tr>
<td>Doan, 1996<sup><xref ref-type="bibr" rid="bibr5-1010539510385220">5</xref></sup></td>
<td>Military students (970)</td>
<td>Hanoi</td>
<td>18-28</td>
<td>21.8</td>
<td>39.3</td>
<td align="center">—</td>
</tr>
<tr>
<td>Nguyen et al, 2000<sup><xref ref-type="bibr" rid="bibr29-1010539510385220">29</xref></sup></td>
<td>University students (140)</td>
<td>Tay Nguyen province</td>
<td>NR</td>
<td>14.3</td>
<td align="center">—</td>
<td align="center">—</td>
</tr>
<tr>
<td>Nguyen, 2003<sup><xref ref-type="bibr" rid="bibr6-1010539510385220">6</xref></sup></td>
<td>Hmong students in a boarding school (115)</td>
<td>Thai Nguyen province</td>
<td>15-19</td>
<td>17.4</td>
<td align="center">—</td>
<td align="center">—</td>
</tr>
<tr>
<td>Nguyen, 2004<sup><xref ref-type="bibr" rid="bibr30-1010539510385220">30</xref></sup></td>
<td>Hmong students in a boarding school (115)</td>
<td>Hoa Binh province</td>
<td>15-19</td>
<td>19.1 (males) 15.4 (female)</td>
<td align="center">—</td>
<td align="center">—</td>
</tr>
<tr>
<td>Katelaris et al, 1995<sup><xref ref-type="bibr" rid="bibr31-1010539510385220">31</xref></sup></td>
<td>Children in rural (87)</td>
<td>Dong Nai province</td>
<td>2-12</td>
<td>19.5</td>
<td/>
<td/>
</tr>
<tr>
<td>Nguyen et al, 2002<sup><xref ref-type="bibr" rid="bibr32-1010539510385220">32</xref></sup></td>
<td>School children (286)</td>
<td>Thai Binh province</td>
<td>9-15</td>
<td>12.9</td>
<td align="center">—</td>
<td align="center">—</td>
</tr>
<tr>
<td>Nguyen et al, 2007<sup><xref ref-type="bibr" rid="bibr8-1010539510385220">8</xref></sup></td>
<td>General population</td>
<td>Thai Binh province</td>
<td>16-82</td>
<td>19.0</td>
<td>41.0</td>
<td>68.2</td>
</tr>
<tr>
<td>Cao, 1995<sup><xref ref-type="bibr" rid="bibr33-1010539510385220">33</xref></sup></td>
<td>Pregnant women (1320)</td>
<td>Hanoi city</td>
<td>NR</td>
<td>13.0</td>
<td align="center">—</td>
<td align="center">—</td>
</tr>
<tr>
<td>Dinh et al, 1996<sup><xref ref-type="bibr" rid="bibr34-1010539510385220">34</xref></sup></td>
<td>Pregnant women (1564)</td>
<td>Hanoi city</td>
<td>18-&gt;40</td>
<td>10.6</td>
<td align="center">—</td>
<td align="center">—</td>
</tr>
<tr>
<td>Chu et al, 2007<sup><xref ref-type="bibr" rid="bibr35-1010539510385220">35</xref></sup></td>
<td>Pregnant women (1300)</td>
<td>Hanoi city</td>
<td>19-41</td>
<td>12.5</td>
<td/>
<td>56.6</td>
</tr>
<tr>
<td>Nguyen et al, 2007<sup><xref ref-type="bibr" rid="bibr7-1010539510385220">7</xref></sup></td>
<td>Fishermen (1075)</td>
<td>Hai Phong city</td>
<td>&lt;20-&gt;50</td>
<td>19.2</td>
<td align="center">—</td>
<td align="center">—</td>
</tr>
<tr>
<td>Ngo et al, 2005<sup><xref ref-type="bibr" rid="bibr36-1010539510385220">36</xref></sup></td>
<td>Children (700)</td>
<td>Thanh Hoa province</td>
<td>3-6</td>
<td>14.1</td>
<td>5.3</td>
<td>6.3</td>
</tr>
<tr>
<td>Cao et al, 2003<sup><xref ref-type="bibr" rid="bibr37-1010539510385220">37</xref></sup></td>
<td>People requesting for vaccination (1841)</td>
<td>Ho Chi Minh city</td>
<td>&lt;10-&gt;50</td>
<td>19.1</td>
<td>34.8</td>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1010539510385220">
<p>Abbreviations: HBV, hepatitis B virus; NR, not reported.</p>
</fn>
<fn id="table-fn2-1010539510385220">
<label>a</label>
<p>Age group in years unless otherwise indicated.</p>
</fn>
<fn id="table-fn3-1010539510385220">
<label>b</label>
<p>Used passive hemagglutination method.</p>
</fn>
<fn id="table-fn4-1010539510385220">
<label>c</label>
<p>HBV DNA(+).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="fig1-1010539510385220" position="float">
<label>Figure 1.</label>
<caption>
<p>HBsAg prevalence in the general population and in healthy subjects by year</p>
</caption>
<graphic xlink:href="10.1177_1010539510385220-fig1.tif"/>
</fig>
<p>Several studies investigated prevalence of HBV infection in high-risk groups, including health care workers (HCWs), blood donors, injecting drug users (IDUs), and patients with or without liver diseases (<xref ref-type="table" rid="table2-1010539510385220">Table 2</xref>). About 12% to 18% of health care workers are positive for HBsAg. Comparison of HBsAg prevalence between HCWs and general population was made in 2 studies,<sup><xref ref-type="bibr" rid="bibr23-1010539510385220">23</xref>,<xref ref-type="bibr" rid="bibr38-1010539510385220">38</xref></sup> which reported insignificant difference (<italic>P</italic> &gt; .05). The results should be interpreted with caution as the sample sizes were small in these 2 studies. Nevertheless, in high endemic regions, early acquisition of HBV through vertical or early life transmission means many health care workers may already be infected with HBV before they started working in the health sector. HCWs in Vietnam have been encouraged to be vaccinated; however, it is neither compulsory nor provided by the government. Notably, HCWs with chronic HBV infection are not forbidden to perform exposure-prone procedures such as open surgery.</p>
<table-wrap id="table2-1010539510385220" position="float">
<label>Table 2.</label>
<caption>
<p>Prevalence of HBV Infection Among High-Risk Groups in Vietnam</p>
</caption>
<graphic alternate-form-of="table2-1010539510385220" xlink:href="10.1177_1010539510385220-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">References</th>
<th align="center">Study Sample (n)</th>
<th align="center">Study Setting</th>
<th align="center">Age Group<sup><xref ref-type="table-fn" rid="table-fn6-1010539510385220">a</xref></sup></th>
<th align="center">HBsAg (%)</th>
<th align="center">Anti-HBs (%)</th>
<th align="center">Anti-HBc (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Vien, 1997<sup><xref ref-type="bibr" rid="bibr39-1010539510385220">39</xref></sup></td>
<td>Health workers (694)</td>
<td>Nha Trang city</td>
<td>18-&gt;50</td>
<td>17.6</td>
<td>52.9</td>
<td align="center">—</td>
</tr>
<tr>
<td>Vu, 1998<sup><xref ref-type="bibr" rid="bibr23-1010539510385220">23</xref></sup></td>
<td>Health workers (89)</td>
<td>Thanh Hoa city</td>
<td>18-60</td>
<td>14.6</td>
<td align="center">—</td>
<td align="center">—</td>
</tr>
<tr>
<td>Duong et al, 2000<sup><xref ref-type="bibr" rid="bibr25-1010539510385220">25</xref></sup></td>
<td>Health workers (170)</td>
<td>Ha Tinh province</td>
<td>NR</td>
<td>12.4</td>
<td>52.4</td>
<td align="center">—</td>
</tr>
<tr>
<td>Nguyen, 2007<sup><xref ref-type="bibr" rid="bibr40-1010539510385220">40</xref></sup></td>
<td>Health workers (669)</td>
<td>Hai Phong city</td>
<td>21-60</td>
<td>8.1</td>
<td>16.4</td>
<td/>
</tr>
<tr>
<td>Hoang et al, 1985<sup><xref ref-type="bibr" rid="bibr41-1010539510385220">41</xref></sup></td>
<td>Volunteer blood donors (573)</td>
<td>Hanoi city<sup><xref ref-type="table-fn" rid="table-fn7-1010539510385220">b</xref></sup></td>
<td>NR</td>
<td>11.5</td>
<td>70.2</td>
<td align="center">—</td>
</tr>
<tr>
<td>Nguyen et al, 1992<sup><xref ref-type="bibr" rid="bibr27-1010539510385220">27</xref></sup></td>
<td>Blood donors (1076)</td>
<td>Hanoi city</td>
<td>18-50</td>
<td>18.0</td>
<td align="center">—</td>
<td align="center">—</td>
</tr>
<tr>
<td>Pham et al, 1994<sup><xref ref-type="bibr" rid="bibr42-1010539510385220">42</xref></sup></td>
<td>Consecutive commercial blood donors (990)</td>
<td>Hanoi and Ho Chi Minh city</td>
<td>32.7-52.9<sup><xref ref-type="table-fn" rid="table-fn8-1010539510385220">c</xref></sup></td>
<td>3.0</td>
<td>48.7</td>
<td align="center">—</td>
</tr>
<tr>
<td>Corwin et al, 1996<sup><xref ref-type="bibr" rid="bibr43-1010539510385220">43</xref></sup></td>
<td>Patients with acute hepatitis (188)</td>
<td>Hanoi city</td>
<td>1-68</td>
<td align="center">—</td>
<td align="center">—</td>
<td>23.9<sup><xref ref-type="table-fn" rid="table-fn9-1010539510385220">d</xref></sup></td>
</tr>
<tr>
<td>Nguyen et al, 1992<sup><xref ref-type="bibr" rid="bibr27-1010539510385220">27</xref></sup></td>
<td>Patients with hepatitis (742)</td>
<td>Hanoi city</td>
<td>NR</td>
<td>43.8</td>
<td align="center">—</td>
<td align="center">—</td>
</tr>
<tr>
<td>Vu, 1998<sup><xref ref-type="bibr" rid="bibr23-1010539510385220">23</xref></sup></td>
<td>Patients with hepatitis (57)</td>
<td>Thanh Hoa city</td>
<td>NA</td>
<td>47.4</td>
<td align="center">—</td>
<td align="center">—</td>
</tr>
<tr>
<td>Kakumu et al, 1998<sup><xref ref-type="bibr" rid="bibr22-1010539510385220">22</xref></sup></td>
<td>Patients with liver diseases (298)</td>
<td>Ho Chi Minh city</td>
<td>26-71</td>
<td>46.6</td>
<td align="center">—</td>
<td align="center">—</td>
</tr>
<tr>
<td>Nguyen et al, 1992<sup><xref ref-type="bibr" rid="bibr27-1010539510385220">27</xref></sup></td>
<td>Patients with cirrhosis (81)</td>
<td>Hanoi city</td>
<td>18-80</td>
<td>49.4</td>
<td align="center">—</td>
<td align="center">—</td>
</tr>
<tr>
<td>Tran et al, 2003<sup><xref ref-type="bibr" rid="bibr26-1010539510385220">26</xref></sup></td>
<td>Patients with cirrhosis (123)</td>
<td>Ho Chi Minh city</td>
<td>NR</td>
<td>30.1<sup><xref ref-type="table-fn" rid="table-fn10-1010539510385220">e</xref></sup></td>
<td align="center">—</td>
<td align="center">—</td>
</tr>
<tr>
<td>Nguyen et al, 1992<sup><xref ref-type="bibr" rid="bibr27-1010539510385220">27</xref></sup></td>
<td>Patients with HCC (78)</td>
<td>Ha Noi city</td>
<td>30-80</td>
<td>57.7</td>
<td align="center">—</td>
<td align="center">—</td>
</tr>
<tr>
<td>Tran et al, 2003<sup><xref ref-type="bibr" rid="bibr26-1010539510385220">26</xref></sup></td>
<td>Patients with HCC (89)</td>
<td>Ho Chi Minh city</td>
<td>NR</td>
<td>34.8</td>
<td align="center">—</td>
<td align="center">—</td>
</tr>
<tr>
<td>La, 1995<sup><xref ref-type="bibr" rid="bibr11-1010539510385220">11</xref></sup></td>
<td>Patients with HCC (94)</td>
<td>Ho Chi Minh city</td>
<td>NR</td>
<td>63.3</td>
<td align="center">—</td>
<td>80.8</td>
</tr>
<tr>
<td>Nguyen et al, 1992<sup><xref ref-type="bibr" rid="bibr27-1010539510385220">27</xref></sup></td>
<td>Patients without liver diseases (1113)</td>
<td>Hanoi city</td>
<td>6-&gt;56</td>
<td>25.2</td>
<td align="center">—</td>
<td align="center">—</td>
</tr>
<tr>
<td>Vu, 1998<sup><xref ref-type="bibr" rid="bibr23-1010539510385220">23</xref></sup></td>
<td>Patients without liver diseases (93)</td>
<td>Thanh Hoa city</td>
<td>NA</td>
<td>19.4</td>
<td align="center">—</td>
<td align="center">—</td>
</tr>
<tr>
<td>La, 1995<sup><xref ref-type="bibr" rid="bibr11-1010539510385220">11</xref></sup></td>
<td>Patients with multiple blood transfusion (128)</td>
<td>Ho Chi Minh city</td>
<td>NR</td>
<td>21.1</td>
<td>42.2</td>
<td>80.5</td>
</tr>
<tr>
<td>La et al, 1995<sup><xref ref-type="bibr" rid="bibr44-1010539510385220">44</xref></sup></td>
<td>IDUs (108)</td>
<td>Ho Chi Minh city</td>
<td>NR</td>
<td>38.0</td>
<td>34.3</td>
<td>94.4</td>
</tr>
<tr>
<td>Vu, 1998<sup><xref ref-type="bibr" rid="bibr23-1010539510385220">23</xref></sup></td>
<td>IDUs and sex workers (47)</td>
<td>Thanh Hoa city</td>
<td>NA</td>
<td>19.2</td>
<td align="center">—</td>
<td align="center">—</td>
</tr>
<tr>
<td>Quan et al. 2009<sup><xref ref-type="bibr" rid="bibr45-1010539510385220">45</xref></sup></td>
<td>IDUs (309)</td>
<td>Bac Ninh province</td>
<td>18-45</td>
<td align="center">—</td>
<td align="center">—</td>
<td>80.9</td>
</tr>
<tr>
<td>Nguyen et al, 2002<sup><xref ref-type="bibr" rid="bibr46-1010539510385220">46</xref></sup></td>
<td>Patients with HIV+ (723)</td>
<td>Quang Ninh province</td>
<td>3 mo-57 y</td>
<td>20.6</td>
<td/>
<td/>
</tr>
<tr>
<td>Vu, 2003<sup><xref ref-type="bibr" rid="bibr47-1010539510385220">47</xref></sup></td>
<td>Patients with HIV+ (178)</td>
<td>Hanoi city</td>
<td>NR</td>
<td>24.7</td>
<td/>
<td/>
</tr>
<tr>
<td>Nguyen et al, 2009<sup><xref ref-type="bibr" rid="bibr48-1010539510385220">48</xref></sup></td>
<td>Patients with HIV+ (889)</td>
<td>Tropical Disease Hospital, Ho Chi Minh city</td>
<td>30<sup><xref ref-type="table-fn" rid="table-fn8-1010539510385220">c</xref></sup></td>
<td>12.3</td>
<td/>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn5-1010539510385220">
<p>Abbreviations: HBV, hepatitis B virus; NR, not reported; NA, not available.</p>
</fn>
<fn id="table-fn6-1010539510385220">
<label>a</label>
<p>Age group by years unless otherwise indicated.</p>
</fn>
<fn id="table-fn7-1010539510385220">
<label>b</label>
<p>Radioimmunoassay used</p>
</fn>
<fn id="table-fn8-1010539510385220">
<label>c</label>
<p>Median age.</p>
</fn>
<fn id="table-fn9-1010539510385220">
<label>d</label>
<p>IgM anti-HBc (+).</p>
</fn>
<fn id="table-fn10-1010539510385220">
<label>e</label>
<p>HBV DNA (+).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The prevalence of HBsAg in voluntary blood donors was similar to that in the general population, ranging from 11.5% to 18.2%.<sup><xref ref-type="bibr" rid="bibr23-1010539510385220">23</xref>,<xref ref-type="bibr" rid="bibr27-1010539510385220">27</xref>,<xref ref-type="bibr" rid="bibr41-1010539510385220">41</xref></sup> In the study by Pham et al,<sup><xref ref-type="bibr" rid="bibr42-1010539510385220">42</xref></sup> the HBsAg prevalence among commercial blood donors was only 3.0% as they had previously given blood and therefore they were screened for HBsAg. Nevertheless, the prevalence of anti-HBs in this study was 48.7%, similar to that in other studies on healthy subjects.</p>
<p>Unlike HCWs and blood donors, hospitalized patients with or without liver diseases have higher rates of HBsAg prevalence (<xref ref-type="table" rid="table2-1010539510385220">Table 2</xref>). One in every 4 to 5 patients without liver disease was positive to HBsAg. Similar results were found in patients with multiple blood transfusions. The prevalence of anti-HBc in patients receiving blood transfusion was double than in the general population (80% vs 40%). Nearly 50% of patients with hepatitis attributed their disease to HBV. Of patients with liver cirrhosis or HCC, up to 80% were positive for HBsAg (<xref ref-type="table" rid="table2-1010539510385220">Table 2</xref>). These figures strongly suggest that HBV is a major cause of liver diseases in Vietnam. Co-infection between HIV and HBV has been reported in several articles with prevalence of HIV-HBV co-infection among IDUs infected with HIV in the range of 12.3% to 24.7%.<sup><xref ref-type="bibr" rid="bibr48-1010539510385220">48</xref>-<xref ref-type="bibr" rid="bibr50-1010539510385220">50</xref></sup> There is very little information on HBV/HCV co-infection. It was reported as 1.2% among patients with hepatitis, 7.7% among patients with liver diseases but much higher in HIV-infected patients (19.1%) and IDUs (25%).<sup><xref ref-type="bibr" rid="bibr22-1010539510385220">22</xref>,<xref ref-type="bibr" rid="bibr44-1010539510385220">44</xref>,<xref ref-type="bibr" rid="bibr47-1010539510385220">47</xref>,<xref ref-type="bibr" rid="bibr51-1010539510385220">51</xref></sup></p>
<p>Although a number of studies were conducted to investigate HBV prevalence, very few studies were community based, and used multistage random sampling methods.<sup><xref ref-type="bibr" rid="bibr3-1010539510385220">3</xref>,<xref ref-type="bibr" rid="bibr8-1010539510385220">8</xref>,<xref ref-type="bibr" rid="bibr9-1010539510385220">9</xref>,<xref ref-type="bibr" rid="bibr19-1010539510385220">19</xref>,<xref ref-type="bibr" rid="bibr20-1010539510385220">20</xref></sup> Most of studies focused on different groups and used convenience sampling methods for subject recruitment from health check-up seekers, students, school children, pregnant women, patients’ visitors, government staff or workers. High-risk groups, including heath workers, blood donors, IDUs, and patients with or without liver diseases were also included.</p>
<p>To estimate age-specific prevalence of HBsAg positivity and to minimize selection bias, we selected only studies that were community based and had similar classification of age groups. Three community-based studies, including 2 conducted in the north (one in urban and one in rural area) and one in the south (rural area) met these criteria.<sup><xref ref-type="bibr" rid="bibr8-1010539510385220">8</xref>,<xref ref-type="bibr" rid="bibr9-1010539510385220">9</xref>,<xref ref-type="bibr" rid="bibr19-1010539510385220">19</xref></sup> The highest prevalence was seen in age group of 30 to 39 years in both genders (19.3% for male and 14.0% for female) followed by age group of 40 to 49 years (18.6% and 13.4%, respectively; <xref ref-type="fig" rid="fig2-1010539510385220">Figure 2</xref>).</p>
<fig id="fig2-1010539510385220" position="float">
<label>Figure 2.</label>
<caption>
<p>Estimated HBsAg+ prevalence by age group and gender</p>
</caption>
<graphic xlink:href="10.1177_1010539510385220-fig2.tif"/>
</fig>
<p>Genotype A-G has been found in the serum of Vietnamese patients infected with HBV.<sup><xref ref-type="bibr" rid="bibr52-1010539510385220">52</xref></sup> Genotype B, C, and D are more common in patients with chronic hepatitis, liver cirrhosis, or HCC,<sup><xref ref-type="bibr" rid="bibr26-1010539510385220">26</xref>,<xref ref-type="bibr" rid="bibr52-1010539510385220">52</xref>-<xref ref-type="bibr" rid="bibr54-1010539510385220">54</xref></sup> whereas genotype A is more frequent in asymptomatic carriers.<sup><xref ref-type="bibr" rid="bibr52-1010539510385220">52</xref></sup> A study of 350 serum samples of asymptomatic HBV carriers, chronic hepatitis B and liver cirrhosis and HCC caused by HBV found that genotype C (25%) is the most common followed by genotype D (20%) and genotype A (18%).<sup><xref ref-type="bibr" rid="bibr52-1010539510385220">52</xref></sup> Genotypes C and D have been documented as independent factors for development of cirrhosis and HCC compared with genotype B whereas patients with genotype B have higher risk of advanced disease compared with those with genotype A.<sup><xref ref-type="bibr" rid="bibr52-1010539510385220">52</xref>,<xref ref-type="bibr" rid="bibr55-1010539510385220">55</xref>-<xref ref-type="bibr" rid="bibr58-1010539510385220">58</xref></sup></p>
</sec>
<sec id="section5-1010539510385220">
<title>Risk Factors for HBV Infection in Vietnam</title>
<p>It is well known that vertical transmission is common in high endemic countries such as Vietnam. However, horizontal transmission also plays an important role in spreading HBV. High prevalence of HBsAg in children, 9.3% to 14.1%, suggested that perinatal and early childhood transmission is a major mode of HBV transmission in Vietnam.<sup><xref ref-type="bibr" rid="bibr20-1010539510385220">20</xref>,<xref ref-type="bibr" rid="bibr32-1010539510385220">32</xref>,<xref ref-type="bibr" rid="bibr36-1010539510385220">36</xref></sup> The rate of current or previous infection was found to linearly increase with age from 19.6% in infants to 79.2% in adults in one study<sup><xref ref-type="bibr" rid="bibr3-1010539510385220">3</xref></sup> and from 51% in the age group of 16 to 19 years to 82% in age group of ≥60 years in another study,<sup><xref ref-type="bibr" rid="bibr8-1010539510385220">8</xref></sup> suggesting ongoing HBV horizontal transmission. A study by Hipgrave et al<sup><xref ref-type="bibr" rid="bibr3-1010539510385220">3</xref></sup> reported that the current infection (HBsAg+) rates were 12.5% in infants, 18.4% in children, 20.5% in adolescents, and 18.8% in adults, indicating that HBV infection is attributable to not only vertical transmission but also, significantly, to horizontal transmission.<sup><xref ref-type="bibr" rid="bibr3-1010539510385220">3</xref></sup> Studies from Hong Kong and Thailand found that ear piercing in females and family history of carriers were independent risk factors of HBV infection among school children.<sup><xref ref-type="bibr" rid="bibr59-1010539510385220">59</xref>,<xref ref-type="bibr" rid="bibr60-1010539510385220">60</xref></sup></p>
<p>Risk factors for HBV infection were reported by a number of studies; however, several studies only used univariate analysis and some defined HBV infection as HBsAg+ and anti-HBs+ but not anti-HBc+.<sup><xref ref-type="bibr" rid="bibr9-1010539510385220">9</xref>,<xref ref-type="bibr" rid="bibr39-1010539510385220">39</xref>,<xref ref-type="bibr" rid="bibr61-1010539510385220">61</xref></sup> Therefore the results should be interpreted with caution. Factors associated with increased risk for HBV infection defined as HBsAg+ and/or anti-HBc+ were only reported in one study in which the authors found that age 60 years or older, district of residence, hospital admission, and history of acupuncture were risk factors for HBV infection.<sup><xref ref-type="bibr" rid="bibr8-1010539510385220">8</xref></sup> Two community-based studies using multivariate analysis reported risk factors for HBsAg+ as household contact with a person with liver disease, reuse of syringes, or history of medical injection and sharing of razors.<sup><xref ref-type="bibr" rid="bibr8-1010539510385220">8</xref>,<xref ref-type="bibr" rid="bibr20-1010539510385220">20</xref></sup> IDUs are known as being at high risk of HBV acquisition. Among HIV-positive IDUs, sharing drugs through frontloading (eg, using a syringe and needle to transfer drugs to another syringe’s barrel when the plunger is withdrawn from the distal end), is associated with HBV infection.<sup><xref ref-type="bibr" rid="bibr49-1010539510385220">49</xref></sup> It is important to note that only 11% of IDUs in this study reported having been vaccinated against HBV.</p>
<p>One cross-sectional seroprevalence study conducted in the north mountainous area of Lao Cai province, involving different ethnicities,<sup><xref ref-type="bibr" rid="bibr20-1010539510385220">20</xref></sup> found that nearly a third of households (29.5%) participating in the study had at least one person currently infected with HBV. Kinh and Day ethnicity had the highest prevalence of HBsAg (nearly 13%) whereas Dao and Phu La had significantly lower prevalence (4.1% and 4.7%, respectively). Although in this study none of the Hmong people was positive with HBsAg—probably because of small sample size (only 30 people), HBsAg prevalence of 19% and 15% were reported among male and female Hmong students, respectively, in another study.<sup><xref ref-type="bibr" rid="bibr30-1010539510385220">30</xref></sup> It is unclear why members of some ethnic groups are at higher risk of HBV infection than others. Further study to investigate the association between cultural, environment, and behavioral factors and HBV exposure is needed to provide evidence-based in development of HBV prevention strategy.</p>
<p>The pooled data from 3 community-based studies showed that overall HBsAg prevalence is higher in males than in females (15% vs 11%, <italic>P</italic> &lt; .001).<sup><xref ref-type="bibr" rid="bibr8-1010539510385220">8</xref>,<xref ref-type="bibr" rid="bibr9-1010539510385220">9</xref>,<xref ref-type="bibr" rid="bibr19-1010539510385220">19</xref></sup> Among these 3 studies only 1 study found a significant difference in HBsAg prevalence between males and females whereas the other 2 found the difference to be insignificant. In the study by Hipgrave et al,<sup><xref ref-type="bibr" rid="bibr3-1010539510385220">3</xref></sup> only teenage males had higher rates of current HBV infection and current or past HBV infection than in females (adjusted <italic>P</italic> &lt; .01).</p>
</sec>
</sec>
<sec id="section6-1010539510385220">
<title>HBV-Related Liver Disease Burden in Vietnam: Current and Future Challenges</title>
<p>Chronic HBV infection is the most important cause of liver disease in Vietnam. Although data on resultant HBV-related liver disease burden are very limited and mainly obtained from hospital-based studies, cross-sectional studies found that 42% to 50% of patients with viral hepatitis, 47.8% to 87.6% of patients with liver cirrhosis, and 34.8% to 80.0% of patients with HCC were positive for HBsAg (<xref ref-type="table" rid="table2-1010539510385220">Table 2</xref>). In addition, genotype C (25.1%) and genotype D (20.3%) are the most common genotypes in HBV-infected Vietnamese individuals, and they are both strongly correlated to liver cirrhosis and HCC development.<sup><xref ref-type="bibr" rid="bibr52-1010539510385220">52</xref></sup></p>
<p>Population-based cancer registry studies have reported that age-standardized incidence rates of liver cancer (per 100 000) were 25.3 for males and 5.9 for females in Ho Chi Minh city<sup><xref ref-type="bibr" rid="bibr62-1010539510385220">62</xref></sup> and 14.0 for males and 3.7 for females in Hanoi.<sup><xref ref-type="bibr" rid="bibr63-1010539510385220">63</xref></sup> The age-standardized incidence rate of HCC per 100 000 people with positive HBsAg in the Hanoi population was estimated to be 166 for males and 58 for females.<sup><xref ref-type="bibr" rid="bibr64-1010539510385220">64</xref></sup> These figures were estimated based on cancer registry notifications, which in Vietnam are likely to be underreported and therefore would underestimate HBV-related HCC incidence.</p>
<p>High prevalence of HBsAg with predominance of genotypes B, C, and D, large population, and long latency of HBV-related liver disease development contribute to a heavy burden on health and economic sectors. As HBV infection is not a notifiable disease in Vietnam, data on morbidity as well as mortality of HBV-related liver disease at national level are not available. A recent study using mathematical modeling reported that Vietnam was facing an enormous HBV-related liver disease burden.<sup><xref ref-type="bibr" rid="bibr2-1010539510385220">2</xref></sup> The estimated number of persons with chronic HBV infection in Vietnam increased from 6.4 million cases in 1990 to 8.4 million in 2005. A slight decrease in chronic HBV prevalence could be only observed between 2003 (8.6 million cases) and 2025 (8 million cases). Incidence of HBV-related liver cirrhosis, HCC, and HBV-related mortality was predicted to increase significantly in the next 15 years. Estimated number of HBV-related LC, HCC, and HBV-related deaths increased from 36 500, 15 600, and 23 300 in 2005 to 58 600, 25 000, and 40 000 in 2025, respectively.<sup><xref ref-type="bibr" rid="bibr2-1010539510385220">2</xref></sup></p>
</sec>
<sec id="section7-1010539510385220">
<title>Public Health Response to HBV Infection in Vietnam</title>
<p>Currently, HBV control in Vietnam relies heavily on universal infant vaccination program, introduced in late 2003, and HBsAg screening for blood donors introduced in the 1990s. Although the coverage rate of HBV vaccination reported is as high as 93% (2006)<sup><xref ref-type="bibr" rid="bibr45-1010539510385220">45</xref></sup> the reduction in prevalence of HBV infection would only be observed in the cohort born from 2003 onward; therefore, as reported in a previous article, the reduction in HBV prevalence of the general population would be insignificant in the next 15 years.<sup><xref ref-type="bibr" rid="bibr2-1010539510385220">2</xref></sup> HBV exposure increased with age and high rates of HBsAg positivity in teenagers, adolescent groups, and those in the age group of 20 to 29 years indicating that horizontal transmission is an important route in spreading HBV. Catch-up vaccination program for children and teenagers born before introducing universal infant HBV vaccination program could prevent horizontal transmission and reduce chronic HBV prevalence more rapidly. However, catch-up vaccination is not currently available for children or teenagers in Vietnam. Lack of knowledge on HBV infection and high cost of HBV vaccine are obstacles for voluntarily vaccination among children and adolescents.</p>
<p>Apart from mother-to-child transmission, household contact has been reported as an independent risk factor for HBV infection, particularly among siblings.<sup><xref ref-type="bibr" rid="bibr8-1010539510385220">8</xref>,<xref ref-type="bibr" rid="bibr20-1010539510385220">20</xref></sup> Transmission related to health care, including hospital admission, acupuncture, and medical injection is also documented.<sup><xref ref-type="bibr" rid="bibr8-1010539510385220">8</xref>,<xref ref-type="bibr" rid="bibr9-1010539510385220">9</xref>,<xref ref-type="bibr" rid="bibr20-1010539510385220">20</xref></sup> However, information on HBV prevention such as brochures, pamphlets, posters, is not available to the public. HBV awareness, therefore, is very low. A survey on knowledge of HBV transmission conducted among heads of household found that less than 12% of 450 respondents had correct answers.<sup><xref ref-type="bibr" rid="bibr20-1010539510385220">20</xref></sup> Improving infection control in health care settings could reduce iatrogenic transmission. Free HBV vaccination should be provided for health care workers to reduce potential transmission between care providers and patients. Our survey on patients’ medical records in a provincial hospital in 2005 found that although almost 100% of patients with liver disease in the Department of Communicable Diseases had been tested for HBsAg, only 51% (119/233) of patients with liver disease in the Department of Internal Medicine and Department of Surgery had received such tests (unpublished data). This suggested a lack of knowledge on HBV information among physicians who are not specialists in communicable diseases. Although, overall HBsAg prevalence in HCWs is similar to that in general population, it was higher in HWS who had direct contact with patients (8.9%) compared with those who had indirect contact with patients (6.3%).<sup><xref ref-type="bibr" rid="bibr40-1010539510385220">40</xref></sup> Low rate of HBV vaccination and lack of HBV knowledge among HCWs were found in a study by Nguyen.<sup><xref ref-type="bibr" rid="bibr40-1010539510385220">40</xref></sup> Only 38.6% of 669 HCWs reported having HBV vaccination. Misconception about HBV transmission and lack of knowledge on progression of HBV infection among HCWs was also reported in this study. For instance, 36% HCWs thought HBV could spread through breast milk, and 17.6% thought HBV could be transmitted through food. Routes of HBV transmission as direct contact with blood or body fluid, sexual activities, and mother-to-child were reported by 88%, 87%, and 78%, respectively, of HCWs. Only 58% to 76% of HCWS knew that HBV infection could lead to chronic hepatitis, liver cirrhosis, and liver cancer.<sup><xref ref-type="bibr" rid="bibr40-1010539510385220">40</xref></sup> Providing knowledge on HBV infection and guidelines on HBV prevention and infection control for health care workers would increase the early detection of HBV infection among patients as well as reduce transmission between patient and care provider in both directions and between patients. Distribution of HBV prevention through different channels, including radio, television, newspapers, brochures, and pamphlets would increase HBV awareness and promote behavior or lifestyles changes and minimize HBV transmission.</p>
<p>There are no data on the rate of people with chronic HBV infection receiving antiviral therapy but presumably, the figure would be very small because of the expensive treatment, high cost of laboratory tests, and whether or not they are aware of their infection status. The consequences of chronic HBV infection among 8 million people currently infected would be a huge burden on economic and health sectors in the future. Increasing the rate of antiviral treatment for people with chronic HBV infection could reduce incidence of liver cirrhosis and HCC. Yet again, with average income per capita per month in 2006 being VND 636 500 (approximately US$40 at exchange rate in 2006),<sup><xref ref-type="bibr" rid="bibr66-1010539510385220">66</xref></sup> antiviral treatment would be unaffordable for many as it is not subsidized by the government.</p>
</sec>
<sec id="section8-1010539510385220">
<title>Recommendations</title>
<p>A strong advocacy campaign for HBV prevention and control needs to be launched to draw attention from the government and Ministry of Health, in particular. A national strategy for HBV prevention and control needs to be urgently established to undertake HBV prevention measures. With a national strategy for HBV prevention and control, systematic measures could be undertaken, including increasing awareness among health workers through the production of national guidelines, training courses, or continuing education. Information on HBV also needs to be disseminated widely among the public through mass media. Besides maintaining high coverage rate of 3-dose HBV (Hep3) immunization among infants, providing a birth dose within 24 hours of birth is also crucial in protecting infants against HBV infection. Although the first dose has been given in a timely manner in most of national and provincial hospitals, it has usually been delayed if infants born in districts hospital or community health centers. Antenatal screening and providing HBIg (hepatitis B specific immune globulin) should be considered for infants born to HBsAg-positive mothers where resources are available. Epidemiological studies on HBV infection, particularly longitudinal studies on HBV-related liver disease, at a population level are required. Such information is essential for planning HBV-related public health services and for the evaluation of the impact of HBV vaccination programs in Vietnam. Currently, HBV prevention and control is underfunded by the government and receives little support from international agencies. With current limited resources, integration HIV control activities with HBV prevention measures funded by either government or international agencies could be advocated. A model similar to reduced prices of antiviral drugs for HIV/AIDS by pharmaceutical companies could be applied to antiviral drugs for HBV treatment.</p>
<p>In conclusion, HBV-related liver disease is and will continue to create a heavy burden for public health in Vietnam in the next several decades unless appropriate interventions are undertaken urgently. HBV prevention and control should be considered a priority in the agenda of the Ministry of Health of Vietnam. To this end, the establishment of a national strategy for HBV prevention and control is a crucial step. The national strategy for HBV prevention and control should link to other national strategies, including the National Strategy on HIV/AIDS Prevention and Control and the National Immunisation Program.</p>
</sec>
</body>
<back>
<ack>
<p>The author would like to thank Professor Daniel Tarantola, The University of New South Wales for his invaluable comments on the manuscript and Dr Pham Thi Dung, Thai Binh Medical University, Vietnam for her assistance in data collection.</p>
</ack>
<fn-group>
<fn fn-type="conflict">
<p>The author(s) declared no potential conflicts of interest with respect to the authorship and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure">
<p>The author(s) received no financial support for the research and/or authorship of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1010539510385220">
<label>1.</label>
<citation citation-type="web">
<collab>World Health Organization</collab>. <source>Hepatitis B, Fact Sheet No. 204</source>. <year>2008</year>. <publisher-loc>Geneva, Switzerland</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2000</year>. <comment>Updated August 2008. <ext-link ext-link-type="uri" xlink:href="http://www.who.int/mediacentre/factsheets/fs204/en/index.html">http://www.who.int/mediacentre/factsheets/fs204/en/index.html</ext-link></comment>. <access-date>Accessed September 13, 2010</access-date>.</citation>
</ref>
<ref id="bibr2-1010539510385220">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nguyen</surname><given-names>VTT</given-names></name>
<name><surname>Law</surname><given-names>MG</given-names></name>
<name><surname>Dore</surname><given-names>GJ</given-names></name>
</person-group>. <article-title>An enormous hepatitis B virus-related liver disease burden projected in Vietnam by 2025</article-title>. <source>Liver Int</source>. <year>2008</year>;<volume>28</volume>:<fpage>525</fpage>-<lpage>531</lpage>.</citation>
</ref>
<ref id="bibr3-1010539510385220">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hipgrave</surname><given-names>DB</given-names></name>
<name><surname>Van</surname><given-names>NT</given-names></name>
<name><surname>Huong</surname><given-names>VM</given-names></name>
<etal/>
</person-group>. <article-title>Hepatitis B infection in rural Vietnam and the implications for a national program of infant immunisation</article-title>. <source>Am J Trop Med Hyg</source>. <year>2003</year>;<volume>69</volume>:<fpage>288</fpage>-<lpage>294</lpage>.</citation>
</ref>
<ref id="bibr4-1010539510385220">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vien</surname><given-names>C</given-names></name>
<name><surname>Nguyen</surname><given-names>T</given-names></name>
<name><surname>Dinh</surname><given-names>S</given-names></name>
</person-group>. <article-title>Investigation of hepatitis B virus infection among emplyees in Nha Trang City</article-title>. <source>J Hyg Prev Med</source>. <year>1996</year>;<volume>6</volume>(<issue>4</issue>):<fpage>34</fpage>-<lpage>40</lpage>.</citation>
</ref>
<ref id="bibr5-1010539510385220">
<label>5.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Doan</surname><given-names>TT</given-names></name>
</person-group>. <source>Investigation on Hepatitis B Virus Infection in Students of Military Institute and Immune Response of HBV Vaccine Produced by the National Institute for Hygiene and Epidemiology</source> [<comment>dissertation, in Vietnamese</comment>]. <publisher-loc>Hanoi, Vietnam</publisher-loc>: <publisher-name>Military Institute of Medicine</publisher-name>; <year>1996</year>.</citation>
</ref>
<ref id="bibr6-1010539510385220">
<label>6.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Nguyen</surname><given-names>TH</given-names></name>
</person-group>. <source>Prevalence of Hepatitis B Virus Infection in Hmong Students of an Ethnic Boarding School</source> [<comment>dissertation, in Vietnamese</comment>]. <publisher-loc>Hanoi, Vietnam</publisher-loc>: <publisher-name>Hanoi Medical University</publisher-name>; <year>2003</year>.</citation>
</ref>
<ref id="bibr7-1010539510385220">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nguyen</surname><given-names>TY</given-names></name>
</person-group>. <article-title>Prevalence of and associated factors for HBsAg positivity among offshore fishermen, Hai Phong city [in Vietnamese]</article-title>. <source>Vietnam Med</source>. <year>2007</year>;<volume>1</volume>:<fpage>150</fpage>-<lpage>157</lpage>.</citation>
</ref>
<ref id="bibr8-1010539510385220">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nguyen</surname><given-names>VT-T</given-names></name>
<name><surname>McLaws</surname><given-names>M-L</given-names></name>
<name><surname>Dore</surname><given-names>G</given-names></name>
</person-group>. <article-title>Highly endemic hepatitis B infection in rural Vietnam</article-title>. <source>J Gastroenterol Hepatol</source>. <year>2007</year>;<volume>22</volume>:<fpage>2093</fpage>-<lpage>2100</lpage>.</citation>
</ref>
<ref id="bibr9-1010539510385220">
<label>9.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Chau</surname><given-names>HH</given-names></name>
</person-group>. <source>An Epidemiological Survey on Viral Hepatitis Infection in a General Population of Tan Chau District, An Giang Province</source> [<comment>dissertation, in Vietnamese</comment>]. <publisher-loc>Hanoi, Vietnam</publisher-loc>: <publisher-name>Institute of Military Medicine</publisher-name>; <year>1995</year>.</citation>
</ref>
<ref id="bibr10-1010539510385220">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chu</surname><given-names>H</given-names></name>
</person-group>. <article-title>HBV markers and mother-child transmission</article-title>. <source>J Prac Med</source>. <year>2007</year>;<volume>6</volume>:<fpage>14</fpage>-<lpage>18</lpage>.</citation>
</ref>
<ref id="bibr11-1010539510385220">
<label>11.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>La</surname><given-names>TN</given-names></name>
</person-group>. <source>Hepatitis B and C Infection in Different Population Groups in Southern Vietnam and Implication for Seeking Blood Donors</source> [<comment>dissertation</comment>]. <publisher-loc>Hanoi, Vietnam</publisher-loc>: <publisher-name>Hanoi Medical University</publisher-name>; <year>1995</year>.</citation>
</ref>
<ref id="bibr12-1010539510385220">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hsu</surname><given-names>H-M</given-names></name>
<name><surname>Lu</surname><given-names>C-F</given-names></name>
<name><surname>Lee</surname><given-names>S-C</given-names></name>
<name><surname>Lin</surname><given-names>S-R</given-names></name>
<name><surname>Chen</surname><given-names>D-S</given-names></name>
</person-group>. <article-title>Seroepidemiologic survey for hepatitis B virus infection in Taiwan: the effect of hepatitis B mass immunosation</article-title>. <source>J Infect Dis</source>. <year>1999</year>;<volume>179</volume>:<fpage>367</fpage>-<lpage>370</lpage>.</citation>
</ref>
<ref id="bibr13-1010539510385220">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ni</surname><given-names>Y-H</given-names></name>
<name><surname>Huang</surname><given-names>L-M</given-names></name>
<name><surname>Chang</surname><given-names>M-H</given-names></name>
<etal/>
</person-group>. <article-title>Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies</article-title>. <source>Gastroenterology</source>. <year>2007</year>;<volume>132</volume>:<fpage>1287</fpage>-<lpage>1293</lpage>.</citation>
</ref>
<ref id="bibr14-1010539510385220">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname><given-names>HL</given-names></name>
<name><surname>Chang</surname><given-names>MH</given-names></name>
<name><surname>Ni</surname><given-names>YH</given-names></name>
<etal/>
</person-group>. <article-title>Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan</article-title>. <source>JAMA</source>. <year>1996</year>;<volume>276</volume>:<fpage>906</fpage>-<lpage>908</lpage>.</citation>
</ref>
<ref id="bibr15-1010539510385220">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chien</surname><given-names>Y-C</given-names></name>
<name><surname>Jan</surname><given-names>C-F</given-names></name>
<name><surname>Kuo</surname><given-names>H-S</given-names></name>
<name><surname>Chen</surname><given-names>C-J</given-names></name>
</person-group>. <article-title>Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched</article-title>. <source>Epidemiol Rev</source>. <year>2006</year>;<volume>28</volume>:<fpage>126</fpage>-<lpage>135</lpage>.</citation>
</ref>
<ref id="bibr16-1010539510385220">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jutavijittum</surname><given-names>P</given-names></name>
<name><surname>Jiviriyawat</surname><given-names>Y</given-names></name>
<name><surname>Yousukh</surname><given-names>A</given-names></name>
<name><surname>Hayashi</surname><given-names>S</given-names></name>
<name><surname>Toriyama</surname><given-names>K</given-names></name>
</person-group>. <article-title>Evaluation of a hepatitis B vaccination program in Chiang Mai, Thailand</article-title>. <source>Southeast Asian J Trop Med Public Health</source>. <year>2005</year>;<volume>36</volume>:<fpage>207</fpage>-<lpage>212</lpage>.</citation>
</ref>
<ref id="bibr17-1010539510385220">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ng</surname><given-names>KP</given-names></name>
<name><surname>Saw</surname><given-names>TL</given-names></name>
<name><surname>Baki</surname><given-names>A</given-names></name>
<name><surname>Rozainah</surname><given-names>K</given-names></name>
<name><surname>Pang</surname><given-names>KW</given-names></name>
<name><surname>Ramanathan</surname><given-names>M</given-names></name>
</person-group>. <article-title>Impact of the Expanded program of immunization against hepatitis B infection in school children in Malaysia</article-title>. <source>Med Microbiol Immunol</source>. <year>2005</year>;<volume>194</volume>:<fpage>163</fpage>-<lpage>168</lpage>.</citation>
</ref>
<ref id="bibr18-1010539510385220">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Goh</surname><given-names>KT</given-names></name>
</person-group>. <article-title>Prevention and control of hepatitis B virus infection in Singapore</article-title>. <source>Ann Acad Med Singapore</source>. <year>1997</year>;<volume>26</volume>:<fpage>671</fpage>-<lpage>681</lpage>.</citation>
</ref>
<ref id="bibr19-1010539510385220">
<label>19.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Tran</surname><given-names>T</given-names></name>
</person-group>. <source>Epidemiological Surveillance for HBV Infection in the Population of Hanoi City</source>. <publisher-loc>Hanoi, Vietnam</publisher-loc>: <publisher-name>The Hanoi Medical University</publisher-name>; <year>1986</year>.</citation>
</ref>
<ref id="bibr20-1010539510385220">
<label>20.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Le</surname><given-names>TKD</given-names></name>
</person-group>. <source>Hepatitis B Infection Among Ethnic Children in Ban Cam Commune, Bao Thang District, Lao Cai Province</source> [<comment>master’s thesis, in Vietnamese</comment>]. <publisher-loc>Hanoi, Vietman</publisher-loc>: <publisher-name>Hanoi Medical University</publisher-name>; <year>2007</year>.</citation>
</ref>
<ref id="bibr21-1010539510385220">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Duong</surname><given-names>TH</given-names></name>
<name><surname>Nguyen</surname><given-names>PH</given-names></name>
<name><surname>Henley</surname><given-names>K</given-names></name>
<name><surname>Peters</surname><given-names>M</given-names></name>
</person-group>. <article-title>Risk factors for hepatitis B infection in rural Vietnam</article-title>. <source>Asian Pac J Cancer Prev</source>. <year>2009</year>;<volume>10</volume>:<fpage>97</fpage>-<lpage>102</lpage>.</citation>
</ref>
<ref id="bibr22-1010539510385220">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kakumu</surname><given-names>S</given-names></name>
<name><surname>Sato</surname><given-names>K</given-names></name>
<name><surname>Morishita</surname><given-names>T</given-names></name>
<etal/>
</person-group>. <article-title>Prevalence of hepatitis B, hepatitis C, and GB virus C/hepatitis G virus infections in liver disease patients and inhabitants in Ho Chi Minh, Vietnam</article-title>. <source>J Med Virol</source>. <year>1998</year>;<volume>54</volume>:<fpage>243</fpage>-<lpage>248</lpage>.</citation>
</ref>
<ref id="bibr23-1010539510385220">
<label>23.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Vu</surname><given-names>HC</given-names></name>
</person-group>. <source>A Survey of HBsAg, Anti-HBs Prevalence in Thanh Hoa City and Immune Response of Hepatitis B Vaccine Produced in Vietnam</source> [<comment>dissertation</comment>]. <publisher-loc>Hanoi, Vietnam</publisher-loc>: <publisher-name>Hanoi Medical University</publisher-name>; <year>1998</year>.</citation>
</ref>
<ref id="bibr24-1010539510385220">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nguyen</surname><given-names>TMT</given-names></name>
<name><surname>Ra-lan</surname><given-names>TH</given-names></name>
</person-group>. <article-title>Rate of HBsAg positive among people tested before HBV vaccination at Ea Kar and Krong Pak districts, Daklak Province</article-title>. <source>J Prac Med</source>. <year>2000</year>;<volume>5</volume>(<issue>380</issue>):<fpage>45</fpage>-<lpage>48</lpage>.</citation>
</ref>
<ref id="bibr25-1010539510385220">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Duong</surname><given-names>CL</given-names></name>
<name><surname>Nguyen</surname><given-names>TV</given-names></name>
<name><surname>Hoang</surname><given-names>TL</given-names></name>
<name><surname>Nguyen</surname><given-names>TTN</given-names></name>
<name><surname>Le</surname><given-names>HL</given-names></name>
</person-group>. <article-title>Investigation results of hepatitis B infection in health workers and healthy people in Hatinh province</article-title>. <source>J Prac Med</source>. <year>2000</year>;<volume>11</volume>:<fpage>16</fpage>-<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr26-1010539510385220">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tran</surname><given-names>HT-T</given-names></name>
<name><surname>Ushijima</surname><given-names>H</given-names></name>
<name><surname>Quang</surname><given-names>VX</given-names></name>
<etal/>
</person-group>. <article-title>Prevalence of hepatitis virus types B through E and genotypic distribution of HBV and HCV in Ho Chi Minh City, Vietnam</article-title>. <source>Hepatol Res</source>. <year>2003</year>;<volume>26</volume>:<fpage>275</fpage>-<lpage>280</lpage>.</citation>
</ref>
<ref id="bibr27-1010539510385220">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nguyen</surname><given-names>VT</given-names></name>
<name><surname>Hoang</surname><given-names>NT</given-names></name>
<name><surname>Fields</surname><given-names>H</given-names></name>
</person-group>. <article-title>Hepatitis A, B, C and D infections in different groups and the implications for producing and using hepatitis B vaccine in Vietnam</article-title>. <source>J Hyg Prev Med</source>. <year>1992</year>;<volume>2</volume>:<fpage>6</fpage>-<lpage>15</lpage>.</citation>
</ref>
<ref id="bibr28-1010539510385220">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cao</surname><given-names>VV</given-names></name>
<name><surname>Tran</surname><given-names>DH</given-names></name>
</person-group>. <article-title>A survey on HBV infection at Hoang Thach Cement Factory 2002</article-title>. <source>J Prev Med</source>. <year>2003</year>;<volume>8</volume>:<fpage>106</fpage>-<lpage>109</lpage>.</citation>
</ref>
<ref id="bibr29-1010539510385220">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nguyen</surname><given-names>XT</given-names></name>
<name><surname>Tran</surname><given-names>TM</given-names></name>
</person-group>. <article-title>The rate of HBsAg positive among students of Medical and Pharmaceutical School, Tay Nguyen University in 1997</article-title>. <source>J Prac Med</source>. <year>2000</year>;<volume>5</volume>:<fpage>4</fpage>-<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr30-1010539510385220">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nguyen</surname><given-names>TVH</given-names></name>
<name><surname>Van</surname><given-names>DH</given-names></name>
</person-group>. <article-title>Prevalence of HBV infection among Hmong students [in Vietnamese]</article-title>. <source>Med J Vietnam</source>. <year>2004</year>.</citation>
</ref>
<ref id="bibr31-1010539510385220">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Katelaris</surname><given-names>PH</given-names></name>
<name><surname>Robertson</surname><given-names>G</given-names></name>
<name><surname>Bradbury</surname><given-names>R</given-names></name>
<name><surname>Tippett</surname><given-names>G</given-names></name>
<name><surname>Hoa</surname><given-names>DQ</given-names></name>
<name><surname>Ngu</surname><given-names>MC</given-names></name>
</person-group>. <article-title>Seroprevalence of hepatitis viruses in children in rural Viet Nam</article-title>. <source>Trans R Soc Trop Med Hyg</source>. <year>1995</year>;<volume>89</volume>:<fpage>487</fpage>.</citation>
</ref>
<ref id="bibr32-1010539510385220">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nguyen</surname><given-names>VTT</given-names></name>
<name><surname>Pham</surname><given-names>KN</given-names></name>
</person-group>. <article-title>Prevalence of HBsAg and HBeAg and risk factors for in school children in two communes of Vu Thu district, Thai Binh province, Vietnam</article-title>. <source>J Prac Med</source>. <year>2002</year>;<volume>433</volume>:<fpage>34</fpage>-<lpage>38</lpage>.</citation>
</ref>
<ref id="bibr33-1010539510385220">
<label>33.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Thuy</surname><given-names>CTT</given-names></name>
</person-group>. <source>Significance of HBV Markers in Preganant Women to Mother-Baby Transmission</source> [<comment>dissertation</comment>]. <publisher-loc>Hanoi, Vietnam</publisher-loc>: <publisher-name>Hanoi Medical University</publisher-name>; <year>1995</year>.</citation>
</ref>
<ref id="bibr34-1010539510385220">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dinh</surname><given-names>TB</given-names></name>
<name><surname>Vu</surname><given-names>BD</given-names></name>
<name><surname>Nguyen</surname><given-names>AT</given-names></name>
<name><surname>Nguyen</surname><given-names>KNH</given-names></name>
</person-group>. <article-title>Hepatitis B infection in pregant women and the role of HBV markers in HBV vertical transmission</article-title>. <source>J Prac Med</source>. <year>1996</year>;<volume>9</volume>:<fpage>24</fpage>-<lpage>26</lpage>.</citation>
</ref>
<ref id="bibr35-1010539510385220">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chu</surname><given-names>HTt</given-names></name>
</person-group>. <article-title>HBV markers and mother-child transmission</article-title>. <source>J Prac Med</source>. <year>2007</year>;<volume>6</volume>:<fpage>14</fpage>-<lpage>18</lpage>.</citation>
</ref>
<ref id="bibr36-1010539510385220">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ngo</surname><given-names>TA</given-names></name>
<name><surname>Quach</surname><given-names>MT</given-names></name>
<name><surname>Nguyen</surname><given-names>DN</given-names></name>
</person-group>. <article-title>Assessment of the status of hepatitis B virus infection in children aged 3-6 years in ThieuHoa district, Thanh Hoa province [in Vietnamese]</article-title>. <source>J Prev Med</source>. <year>2005</year>;<volume>XV</volume>(<issue>1</issue>):<fpage>155</fpage>-<lpage>158</lpage>.</citation>
</ref>
<ref id="bibr37-1010539510385220">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cao</surname><given-names>N</given-names></name>
<name><surname>Pham</surname><given-names>T</given-names></name>
<name><surname>Nguyen</surname><given-names>D</given-names></name>
</person-group>. <article-title>Hepatitis B infection among people visiting clinics for vaccination</article-title>. <source>J Prac Med</source>. <year>2003</year>;<volume>2</volume>:<fpage>111</fpage>-<lpage>113</lpage>.</citation>
</ref>
<ref id="bibr38-1010539510385220">
<label>38.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Duong</surname><given-names>CL</given-names></name>
</person-group>. <source>An Epidemiology Study on Hepatitis B Infection in Ha Tinh Province</source> [<comment>dissertation</comment>]. <publisher-loc>Hanoi, Vietnam</publisher-loc>: <publisher-name>National Institute for Hygiene and Epidemiology</publisher-name>; <year>2001</year>.</citation>
</ref>
<ref id="bibr39-1010539510385220">
<label>39.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Vien</surname><given-names>CC</given-names></name>
</person-group>. <source>Investigation on Hepatitis B Infection in Some Cities of Central Vietnam and Effects of Hepatitis B Vaccination</source> [<comment>dissertation</comment>]. <publisher-loc>Hanoi, Vietnam</publisher-loc>: <publisher-name>National Institute of Hygiene and Epidemiology</publisher-name>; <year>1997</year>.</citation>
</ref>
<ref id="bibr40-1010539510385220">
<label>40.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Nguyen</surname><given-names>QT</given-names></name>
</person-group>. <source>Prevalence of HBV Infection and HBV Knowledge Among Health Workers of Three Hospitals in Hai Phong City</source> [<comment>dissertation</comment>]. <publisher-loc>Thai Binh, Vietnam</publisher-loc>: <publisher-name>Thai Binh Medical University</publisher-name>; <year>2007</year>.</citation>
</ref>
<ref id="bibr41-1010539510385220">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hoang</surname><given-names>B</given-names></name>
<name><surname>Simonneau</surname><given-names>M</given-names></name>
<name><surname>Le Xuan</surname><given-names>P</given-names></name>
<name><surname>Audat</surname><given-names>F</given-names></name>
<name><surname>Guichoux</surname><given-names>P</given-names></name>
<name><surname>Jaulmes</surname><given-names>B</given-names></name>
</person-group>. <article-title>Prevalence of hepatitis B viral markers in Vietnamese blood donors [in French]</article-title>. <source>Rev Fr Transfus Immunohematol</source>. <year>1985</year>;<volume>28</volume>:<fpage>227</fpage>-<lpage>236</lpage>.</citation>
</ref>
<ref id="bibr42-1010539510385220">
<label>42.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pham</surname><given-names>S</given-names></name>
<name><surname>Dao</surname><given-names>DD</given-names></name>
<name><surname>Bui</surname><given-names>H</given-names></name>
<etal/>
</person-group>. <article-title>Makers of hepatitis C and B virus infections among blood donors in Ho Chi Minh and Hanoi, Vietnam</article-title>. <source>Clin Diagn Lab Immunol</source>. <year>1994</year>;<volume>1</volume>:<fpage>413</fpage>-<lpage>418</lpage>.</citation>
</ref>
<ref id="bibr43-1010539510385220">
<label>43.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Corwin</surname><given-names>AL</given-names></name>
<name><surname>Dai</surname><given-names>TC</given-names></name>
<name><surname>Duc</surname><given-names>DD</given-names></name>
<etal/>
</person-group>. <article-title>Acute viral hepatitis in Hanoi, Viet Nam</article-title>. <source>Trans R Soc Trop Med Hyg</source>. <year>1996</year>;<volume>90</volume>:<fpage>647</fpage>.</citation>
</ref>
<ref id="bibr44-1010539510385220">
<label>44.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>La</surname><given-names>TN</given-names></name>
<name><surname>Ta</surname><given-names>TV</given-names></name>
</person-group>. <article-title>Hepatitis B and hepatitis C virus infection in injecting drug users at a rehabilitation centre in Thu Duc, Ho Chi Minh City</article-title>. <source>J Prac Med</source>. <year>1995</year>;<volume>316</volume>(<issue>6</issue>):<fpage>21</fpage>-<lpage>22</lpage>.</citation>
</ref>
<ref id="bibr45-1010539510385220">
<label>45.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Quan</surname><given-names>VM</given-names></name>
<name><surname>Go</surname><given-names>VF</given-names></name>
<name><surname>Nam</surname><given-names>LV</given-names></name>
<etal/>
</person-group>. <article-title>Risks for HIV, HBV, and HCV infections among male injection drug users in northern Vietnam: a case-control study</article-title>. <source>AIDS Care</source>. <year>2009</year>;<volume>21</volume>:<fpage>7</fpage>-<lpage>16</lpage>.</citation>
</ref>
<ref id="bibr46-1010539510385220">
<label>46.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nguyen</surname><given-names>TTM</given-names></name>
<name><surname>Nguyen</surname><given-names>NT</given-names></name>
<name><surname>Vu</surname><given-names>VT</given-names></name>
<etal/>
</person-group>. <article-title>Prevalence of HBV and HCV among patients with HIV positivity</article-title>. <source>Vietnam Med</source>. <year>2002</year>;<volume>8</volume>:<fpage>27</fpage>-<lpage>32</lpage>.</citation>
</ref>
<ref id="bibr47-1010539510385220">
<label>47.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Vu</surname><given-names>DV</given-names></name>
</person-group>. <source>Prevalence of HCV Infection Among Patients Infected With HIV and Patients With Viral Hepatitis at the National Institute for Clinical Research in Tropical Medicine Between 1999 and 2003</source>. <publisher-loc>Hanoi, Vietman</publisher-loc>: <publisher-name>Hanoi Medical University</publisher-name>; <year>2003</year>.</citation>
</ref>
<ref id="bibr48-1010539510385220">
<label>48.</label>
<citation citation-type="confproc">
<person-group person-group-type="editor">
<name><surname>Nguyen</surname><given-names>TC</given-names></name>
<name><surname>Vo</surname><given-names>MQ</given-names></name>
<name><surname>Vo</surname><given-names>TTN</given-names></name>
<name><surname>Colby</surname><given-names>D</given-names></name>
</person-group>, eds. <article-title>First-line antoretroviral therapy outcomes in HIV-infected adults in Ho Chi Minh city, Vietnam</article-title>. <conf-name>Proceedings of the 17th Conference on Retroviruses and Opportunistic Infections</conf-name>; <year>2010</year>; <conf-loc>San Francisco, CA</conf-loc>.</citation>
</ref>
<ref id="bibr49-1010539510385220">
<label>49.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Quan</surname><given-names>VM</given-names></name>
<name><surname>Go</surname><given-names>VF</given-names></name>
<name><surname>Nam le</surname><given-names>V</given-names></name>
<etal/>
</person-group>. <article-title>Risks for HIV, HBV, and HCV infections among male injection drug users in northern Vietnam: a case–control study</article-title>. <source>AIDS Care</source>. <year>2009</year>;<volume>21</volume>:<fpage>7</fpage>-<lpage>16</lpage>.</citation>
</ref>
<ref id="bibr50-1010539510385220">
<label>50.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Le</surname><given-names>KO</given-names></name>
<name><surname>Ngo</surname></name>
</person-group>. <article-title>HBV and HCV co-infection among injecting drug users with HIV+</article-title>. <source>Bull Med Pharm</source>. <year>2004</year>.</citation>
</ref>
<ref id="bibr51-1010539510385220">
<label>51.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nguyen</surname><given-names>TTM</given-names></name>
<name><surname>Nguyen</surname><given-names>NT</given-names></name>
<name><surname>Vu</surname><given-names>VT</given-names></name>
<etal/>
</person-group>. <article-title>Prevalence of HBV and HCV among patients with HIV positive</article-title>. <source>Med J Vietnam</source>. <year>2002</year>;<volume>8</volume>:<fpage>27</fpage>-<lpage>31</lpage>.</citation>
</ref>
<ref id="bibr52-1010539510385220">
<label>52.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Toan</surname><given-names>NL</given-names></name>
<name><surname>Song</surname><given-names>LH</given-names></name>
<name><surname>Kremsner</surname><given-names>PG</given-names></name>
<etal/>
</person-group>. <article-title>Impact of the hepatitis B virus genotype and genotype mixtures on the course of liver disease in Vietnam</article-title>. <source>Hepatology</source>. <year>2006</year>;<volume>43</volume>:<fpage>1375</fpage>-<lpage>1384</lpage>.</citation>
</ref>
<ref id="bibr53-1010539510385220">
<label>53.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Thuy le</surname><given-names>TT</given-names></name>
<name><surname>Ryo</surname><given-names>H</given-names></name>
<name><surname>Van Phung</surname><given-names>L</given-names></name>
<name><surname>Furitsu</surname><given-names>K</given-names></name>
<name><surname>Nomura</surname><given-names>T</given-names></name>
</person-group>. <article-title>Distribution of genotype/subtype and mutational spectra of the surface gene of hepatitis B virus circulating in Hanoi, Vietnam</article-title>. <source>J Med Virol</source>. <year>2005</year>;<volume>76</volume>:<fpage>161</fpage>-<lpage>169</lpage>.</citation>
</ref>
<ref id="bibr54-1010539510385220">
<label>54.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Truong</surname><given-names>BX</given-names></name>
<name><surname>Seo</surname><given-names>Y</given-names></name>
<name><surname>Yano</surname><given-names>Y</given-names></name>
<etal/>
</person-group>. <article-title>Genotype and variations in core promoter and pre-core regions are related to progression of disease in HBV-infected patients from Northern Vietnam</article-title>. <source>Int J Mol Med</source>. <year>2007</year>;<volume>19</volume>:<fpage>293</fpage>-<lpage>299</lpage>.</citation>
</ref>
<ref id="bibr55-1010539510385220">
<label>55.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chan</surname><given-names>HLY</given-names></name>
<name><surname>Hui</surname><given-names>AY</given-names></name>
<name><surname>Wong</surname><given-names>ML</given-names></name>
<etal/>
</person-group>. <article-title>Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma</article-title>. <source>Gut</source>. <year>2004</year>;<volume>53</volume>:<fpage>1494</fpage>-<lpage>1498</lpage>.</citation>
</ref>
<ref id="bibr56-1010539510385220">
<label>56.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chu</surname><given-names>C-M</given-names></name>
<name><surname>Liaw</surname><given-names>Y-F</given-names></name>
</person-group>. <article-title>Genotype C hepatitis B virus infection is associated with a higher risk of reactivation of hepatitis B and progression to cirrhosis than genotype B: a longitudinal study of hepatitis B e antigen-positive patients with normal aminotransferase levels at baseline</article-title>. <source>J Hepatol</source>. <year>2005</year>;<volume>43</volume>:<fpage>411</fpage>-<lpage>417</lpage>.</citation>
</ref>
<ref id="bibr57-1010539510385220">
<label>57.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kao</surname><given-names>JH</given-names></name>
<name><surname>Chen</surname><given-names>PJ</given-names></name>
<name><surname>Lai</surname><given-names>MY</given-names></name>
<name><surname>Chen</surname><given-names>DS</given-names></name>
</person-group>. <article-title>Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B</article-title>. <source>Gastroenterology</source>. <year>2000</year>;<volume>118</volume>:<fpage>554</fpage>-<lpage>559</lpage>.</citation>
</ref>
<ref id="bibr58-1010539510385220">
<label>58.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nakayoshi</surname><given-names>T</given-names></name>
<name><surname>Maeshiro</surname><given-names>T</given-names></name>
<name><surname>Nakayoshi</surname><given-names>T</given-names></name>
<etal/>
</person-group>. <article-title>Difference in prognosis between patients infected with hepatitis B virus with genotype B and those with genotype C in the Okinawa Islands: a prospective study</article-title>. <source>J Med Virol</source>. <year>2003</year>;<volume>70</volume>:<fpage>350</fpage>-<lpage>354</lpage>.</citation>
</ref>
<ref id="bibr59-1010539510385220">
<label>59.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Luksamijarulkul</surname><given-names>P</given-names></name>
<name><surname>Maneesri</surname><given-names>P</given-names></name>
<name><surname>Kittigul</surname><given-names>L</given-names></name>
</person-group>. <article-title>Hepatitis B sero-prevalence and risk factors among school-age children in a low socioeconomic community, Bangkok</article-title>. <source>Asia Pac J Public Health</source>. <year>1995</year>;<volume>8</volume>:<fpage>158</fpage>-<lpage>161</lpage>.</citation>
</ref>
<ref id="bibr60-1010539510385220">
<label>60.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname><given-names>A</given-names></name>
<name><surname>Cheng</surname><given-names>FF</given-names></name>
<name><surname>Chan</surname><given-names>CS</given-names></name>
<name><surname>Lau</surname><given-names>LC</given-names></name>
<name><surname>Lo</surname><given-names>AS</given-names></name>
</person-group>. <article-title>Sero-epidemiology and risk factors of positive hepatitis B surface antigen amongst Chinese adolescents</article-title>. <source>Asia Pac J Public Health</source>. <year>2001</year>;<volume>13</volume>:<fpage>30</fpage>-<lpage>35</lpage>.</citation>
</ref>
<ref id="bibr61-1010539510385220">
<label>61.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ha</surname><given-names>TMT</given-names></name>
<name><surname>Vo</surname><given-names>HT</given-names></name>
<name><surname>Nguyen</surname><given-names>HV</given-names></name>
</person-group>. <article-title>Investigating risk factors for HBsAg positivity</article-title>. <source>J Prac Med</source>. <year>2002</year>;<volume>3</volume>:<fpage>57</fpage>-<lpage>59</lpage>.</citation>
</ref>
<ref id="bibr62-1010539510385220">
<label>62.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nguyen</surname><given-names>MQ</given-names></name>
<name><surname>Nguyen</surname><given-names>CH</given-names></name>
<name><surname>Parkin</surname><given-names>DM</given-names></name>
</person-group>. <article-title>Cancer incidence in Ho Chi Minh City, Viet Nam, 1995-1996</article-title>. <source>Int J Cancer</source>. <year>1998</year>;<volume>76</volume>:<fpage>472</fpage>-<lpage>479</lpage>.</citation>
</ref>
<ref id="bibr63-1010539510385220">
<label>63.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Anh</surname><given-names>PT</given-names></name>
<name><surname>Parkin</surname><given-names>DM</given-names></name>
<name><surname>Hanh</surname><given-names>NT</given-names></name>
<name><surname>Duc</surname><given-names>NB</given-names></name>
</person-group>. <article-title>Cancer in the population of Hanoi, Vietnam, 1988-1990</article-title>. <source>Br J Cancer</source>. <year>1993</year>;<volume>68</volume>:<fpage>1236</fpage>-<lpage>1242</lpage>.</citation>
</ref>
<ref id="bibr64-1010539510385220">
<label>64.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Le</surname><given-names>TN</given-names></name>
<name><surname>Yoshimura</surname><given-names>T</given-names></name>
</person-group>. <article-title>Estimate of the incidence of hepatocellular carcinoma among carriers of HBsAg(+) in the general population of Hanoi, Vietnam from 1991-1993</article-title>. <source>Asian Pac J Cancer Prev</source>. <year>2001</year>;<volume>2</volume>:<fpage>309</fpage>-<lpage>314</lpage>.</citation>
</ref>
<ref id="bibr65-1010539510385220">
<label>65.</label>
<citation citation-type="web">
<collab>World Health Organization</collab>. <article-title>Immunization surveillance, assessment and monitoring: third dose of hepatitis B vaccine: reported estimates of HepB3 coverage</article-title>. <source>Geneva, Switzerland: World Health Organization</source>; <year>2009</year>. <comment><ext-link ext-link-type="uri" xlink:href="http://www.who.int/immunization_monitoring/en/globalsummary/timeseries/tscoveragehepb3.htm">http://www.who.int/immunization_monitoring/en/globalsummary/timeseries/tscoveragehepb3.htm</ext-link></comment>. <access-date>Accessed September 13, 2010</access-date>.</citation>
</ref>
<ref id="bibr66-1010539510385220">
<label>66.</label>
<citation citation-type="book">
<article-title>General Statistics Office of Vietnam</article-title>. <source>Living Standard Survey 2006: Monthly Income Per Capita by Urban, Rural, Sex of Household Head, Region and Income Quintile (at Current Prices)</source>. <publisher-loc>Hanoi, Vietnam</publisher-loc>: <publisher-name>General Statistics Office of Vietnam</publisher-name>; <year>2009</year>.</citation>
</ref>
</ref-list>
</back>
</article>